Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ongoing ESC Congress in Munich, Germany.
Surabhi Dangi-Garimella, PhD
Advertisement
Articles by Surabhi Dangi-Garimella, PhD
Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ESC Congress in Munich, Germany.
Annual meeting explores how to overcome the challenges with patient care that community oncology practices face on a daily basis.
A new study found financial integration between physicians and hospitals has led to higher spending in outpatient care.
Advertisement
Latest Updated Articles
Trial Results Confirm Aspirin Prevents Primary Vascular Events in Patients With DiabetesPublished: August 27th 2018 | Updated:
Health Care Integration May Increase Commercial Health SpendPublished: October 20th 2015 | Updated:
ASCEND Trial: Aspirin Prevents Serious Vascular Events in DiabetesPublished: August 27th 2018 | Updated:
Community Oncology Alliance Explores Challenges in Cancer Patient CarePublished: April 23rd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
2
FDA Approves First Drug for Pediatrics With Irritable Bowel Syndrome With Constipation
3
Regular Melatonin Supplementation May Hide Hidden Heart Complications
4
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
5
